Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

143 results about "Loop of Henle" patented technology

In the kidney, the loop of Henle (English: /ˈhɛnli/) (or Henle's loop, Henle loop, nephron loop or its Latin counterpart ansa nephroni) is the portion of a nephron that leads from the proximal convoluted tubule to the distal convoluted tubule. Named after its discoverer, the German anatomist Friedrich Gustav Jakob Henle, the loop of Henle's main function is to create a concentration gradient in the medulla of the kidney.

Expandable catheter system for peri-ostial injection and muscle and nerve fiber ablation

ActiveUS20120271277A1Improve control and treatmentTime efficient and safeElectrocardiographySurgical needlesCapital equipmentLeft atrium
At the present time, physicians often treat patients with atrial fibrillation (AF) using radiofrequency (RF) catheter systems to ablate conducting tissue in the wall of the Left Atrium of the heart around the ostium of the pulmonary veins. These systems are expensive and take time consuming to use. The present invention circular ablation system CAS includes a multiplicity of expandable needles that can be expanded around a central axis and positioned to inject a fluid like ethanol to ablate conductive tissue in a ring around the ostium of a pulmonary vein quickly and without the need for expensive capital equipment. The expansion of the needles is accomplished by self-expanding or balloon expandable structures. The invention includes centering means so that the needles will be situated in a pattern surrounding the outside of the ostium of a vein. Also included are members that limit the distance of penetration of the needles into the wall of the left atrium, or the aortic wall. The present invention also has an important application to ablate tissue around the ostium of one or both renal arteries, for the ablation of the sympathetic nerve fibers and/or other afferent or efferent nerves going to or from each kidney in order to treat hypertension.
Owner:ABLATIVE SOLUTIONS INC

Short Legged Bifurcated Stent Graft Distal Capture Element and Method

A bifurcated stent graft section includes a plurality of loops formed from a serpentine support wire forming a stent at a distal end of one of the short legs of the bifurcated stent graft section. A delivery system includes a coil having a wire configured to pass through the loops and prevent disengagement of the loops from the delivery system without relative rotational movement between the coil and the loops. In a method for delivery the bifurcated stent graft section, the bifurcated stent graft section is advanced to the treatment site, a sheath is retracted to deploy the proximal end of the bifurcated stent graft section while the coil retains the distal end of one of the short legs of the bifurcated stent graft section. A second guidewire is threaded into the short leg of the bifurcated stent graft section which is been stabilized by being held by the coil of the delivery system. An extension leg graft is delivered over the second guidewire and deployed to be coupled to the other short leg of the bifurcated stent graft section while the coil retains the loops. The coil is rotated to release the loops and allow the bifurcated stent graft section to fully deploy. A second extension leg graft is delivered and coupled to the other leg of the bifurcated stent graft section to complete the construction of a bifurcated stent graft in situ.
Owner:MEDTRONIC VASCULAR INC

Method and apparatus for percutaneous aortic valve replacement

A method for percutaneous aortic valve (PAV) replacement and a temporary aortic valve used to facilitate the same. The temporary valve is comprised of a reversibly expandable occluding means, such as balloons, surrounding a central catheter mechanism. The temporary valve is positioned within the ascending aorta, just above and downstream from the coronary ostia. The occluding means is configured such that, when fully expanded against the aortic wall, gaps are left that promote continuous coronary perfusion during the cardiac cycle. The native aortic valve is next dilated, and then ablated through deployment of an ablation stent. The ablation stent displaces the native valve tissues and remains within the aortic annulus to receive and retain the PAV. The PAV can then be positioned and deployed within the ablation stent with precision and ease. Ablation of the native aortic valve removes the structural obstacles to precise PAV placement. The temporary aortic valve mediates the hemodynamic forces encountered by the surgeon following native valve ablation. The temporary valve also promotes patient stability through continuous coronary perfusion and a moderated transvavlular pressure gradient. Mathematical considerations for determining the optimum cross-sectional area for the temporary valve blood perfusion gaps are also described.
Owner:HOCOR CARDIOVASCULAR TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products